Oruka Therapeutics, Inc. (ORKA)

SEC filing

Oruka Therapeutics, Inc.

ORKA · CIK 907654

4 · Oct 13, 2026 · Senior Vice President, Finance Agarwal Arjun sold 9,999 shares at $80.60/share ($805.9K); exercised options for 20.00K shares

Senior Vice President, Finance Agarwal Arjun sold 9,999 shares at $80.60/share ($805.9K); exercised options for 20.00K shares

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov